All updates
All updates
today 37STAT News精选评分4040 BioPharma Dive评分4141 Novo to pay Hengrui up to $2.6B for a once-weekly obesity pill
监管与产业动态评分1010 We'll be in Basel for BioTechX Europe next week! Visit booth #420 to see why 14 of the top 20 pharma companies use Seqera for enterprise-scale bioinformatics.🎤 Catch our talk Oct 6 at 15:30 CEST, or register for the recording. hubs.la/Q04yBMgG0
Endpoints News评分2020 SK pharmteco unveils $200M+ investment to expand CDMO capabilities
Endpoints News评分00 Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing
STAT News评分55 STAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
STAT News精选评分4343 STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
BioSpace精选评分5252 Summit snags $2B investment from AstraZeneca, clearing financial overhang
STAT News评分3333 STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
Endpoints News评分2020 ARCH and Population Health return to China for new startup Somnivera, targeting sleep
Endpoints News评分55 After GLP-1s, biosimilars are the new frontier in direct-to-employer plans
Endpoints News评分1010 Spark co-founder Steven Altschuler is back with an immune-resetting biotech
监管与产业动态评分77 Audien beams up William Shatner to boldly boost OTC hearing aid awareness - Fierce Pharma
BioPharma Dive评分3232 ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
BioPharma Dive评分4848 AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
BioSpace评分4545 Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
Endpoints News评分2424 AI health startup Ortet launches with $500M and co-founders from Genentech
监管与产业动态评分99 Inizio Evoke names new leaders in media, AI and client accounts - Fierce Pharma
监管与产业动态精选评分4242 Signal or noise? > Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #healthcare #pharma #pharmaceutical
监管与产业动态精选评分3939 Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui - Fierce Biotech
BioSpace评分2727 3 steps for taking on Novartis in radiopharma: Curium up first
中文产业新闻Chinese source评分2626 默沙东21.3亿美元引进思璞锐KRAS G12D分子胶SPR2015
文献与产业新闻评分1515 CAR T start-up Link Cell names BMS, SystImmune vet Jie D’Elia CEO
文献与产业新闻精选评分6868 Merck turns to China-based SciBrunch for KRAS program, pays $400M up front: Deals Report
监管与产业动态评分55 Boston Scientific - Fierce Pharma
监管与产业动态评分2121 BioNTech to close 3 sites in Germany after failed buyer search - Fierce Pharma
监管与产业动态评分1414 Eli Lilly's new initiative will take GLP-1s to lower-income nations - Fierce Pharma
BioSpace精选评分4545 Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
监管与产业动态精选评分3939 Scynexis bags $214M BARDA contract for antifungal development - Fierce Biotech
监管与产业动态评分2121 Tolerance continues thymus-focused deals with $560M pact for Tanabe's clinical-stage IL-33 drug - Fierce Biotech
监管与产业动态评分3030 Precision Neuroscience taps $250M in Series D funding for brain-computer interface - Fierce Biotech
中文产业新闻精选Chinese source评分5454 思璞锐与默沙东就口服 KRAS G12D 抑制剂 SPR2015 达成全球授权协议，首付 4 亿美元
监管与产业动态评分2222 VC Sofinnova reels in €82M to target medtechs in the next 5 years - Fierce Biotech
监管与产业动态评分2121 Merck pens $2.1B deal with China’s SciBrunch to chase KRAS G12D - Fierce Biotech
中文产业新闻精选Chinese source评分5050 思璞锐与默沙东就在研口服KRAS G12D(ON)抑制剂SPR2015达成全球独家授权协议
监管与产业动态评分1717 Signal or noise? > SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients - The… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #competitivemarketing #biotech
监管与产业动态评分77 Merck's holistic HIV health hive buzzes with the help of actress Debbie Allen - Fierce Pharma
监管与产业动态评分66 Signal or noise? > Cas9 mRNA in Vitro Transcribed Market To 2035: Growth Driven by Gene Editing Scale-Up - News and Statistics - IndexBox >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
文献与产业新闻精选评分3535 STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic
文献与产业新闻评分1515 More IPO hopefuls aim to echo ADARx’s first-day pop: Public Equity Report